OTCMKTS:ABCZY - ABCAM PLC/ADR Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $18.00 0.00 (0.00 %) (As of 07/20/2018 12:48 PM ET)Previous Close$18.00Today's Range$18.00 - $18.0052-Week Range$12.7506 - $19.03Volume65 shsAverage Volume838 shsMarket Capitalization$3.69 billionP/E RatioN/ADividend Yield0.43%Beta1.38 Company ProfileDividend HistoryHeadlinesSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies, biochemicals, isotype controls, flow cytometry multi-color selectors, kits, loading controls, lysates, peptides, proteins, slides, tags and cell markers, and tools and reagents. Its products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics and nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells, as well as in drug discovery products and services. Abcam plc also engages in sales and distribution, and financing and investing activities, as well as sells its products online. It offers validated antibodies and other binders, and assays to the research and clinical communities to help advance the understanding of biology and causes of disease. Abcam plc was founded in 1998 and is headquartered in Cambridge, the United Kingdom. Receive ABCZY News and Ratings via Email Sign-up to receive the latest news and ratings for ABCZY and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Industrial inorganic chemicals, not elsewhere classified Sub-IndustryN/A SectorMedical SymbolOTCMKTS:ABCZY CUSIPN/A WebN/A PhoneN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous EmployeesN/A Outstanding Shares204,960,000Market Cap$3,689.28 ABCAM PLC/ADR (OTCMKTS:ABCZY) Frequently Asked Questions What is ABCAM PLC/ADR's stock symbol? ABCAM PLC/ADR trades on the OTCMKTS under the ticker symbol "ABCZY." How often does ABCAM PLC/ADR pay dividends? What is the dividend yield for ABCAM PLC/ADR? ABCAM PLC/ADR declared a Semi-Annual dividend on Monday, March 5th. Stockholders of record on Friday, March 16th will be paid a dividend of $0.038 per share on Thursday, April 26th. The ex-dividend date of this dividend is Thursday, March 15th. View ABCAM PLC/ADR's Dividend History. What is the consensus analysts' recommendation for ABCAM PLC/ADR? 0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ABCAM PLC/ADR in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A." Who are some of ABCAM PLC/ADR's key competitors? Some companies that are related to ABCAM PLC/ADR include GRIFOLS S A/S (GRFS), IPSEN S A/S (IPSEY), H. Lundbeck A/S- (HLUYY), OLYMPUS Corp/S (OCPNY), Novozymes A/S (NVZMF), Merck KGaA (MKGAF), GENMAB A/S/S (GMXAY), Ramsay Health Care Limited Fully Paid Ord. Shrs (RHC), Teleflex (TFX), Ono Pharmaceutical (OPHLF), MERCK KGAA/S (MKKGY), Davita (DVA), Cooper Companies (COO), Straumann (SAUHF) and SONOVA Hldg AG/ADR (SONVY). Who are ABCAM PLC/ADR's key executives? ABCAM PLC/ADR's management team includes the folowing people: Mr. Alan Thomas Hirzel BS, MS, MBA, CEO & Exec. Director (Age 50)Dr. Jonathan Simon Milner, Co-Founder and Non-Exec. Deputy Chairman (Age 53)Mr. Gavin Hilary James Wood BA (Hons), ACA, CFO & Exec. Director (Age 48)Mr. Sean Hickey BSc, Chief Information OfficerJames Staveley, VP of Investor Relations Has ABCAM PLC/ADR been receiving favorable news coverage? News stories about ABCZY stock have been trending somewhat positive on Friday, according to Accern Sentiment Analysis. The research firm identifies negative and positive news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. ABCAM PLC/ADR earned a daily sentiment score of 0.12 on Accern's scale. They also gave news stories about the company an impact score of 45.57 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the immediate future. How do I buy shares of ABCAM PLC/ADR? Shares of ABCZY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is ABCAM PLC/ADR's stock price today? One share of ABCZY stock can currently be purchased for approximately $18.00. How big of a company is ABCAM PLC/ADR? ABCAM PLC/ADR has a market capitalization of $3.69 billion. MarketBeat Community Rating for ABCAM PLC/ADR (OTCMKTS ABCZY)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 63 (Vote Outperform)Underperform Votes: 69 (Vote Underperform)Total Votes: 132MarketBeat's community ratings are surveys of what our community members think about ABCAM PLC/ADR and other stocks. Vote "Outperform" if you believe ABCZY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ABCZY will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/20/2018 by MarketBeat.com StaffFeatured Article: Should you buy a closed-end mutual fund?